<SEC-DOCUMENT>0001213900-25-077488.txt : 20250815
<SEC-HEADER>0001213900-25-077488.hdr.sgml : 20250815
<ACCEPTANCE-DATETIME>20250815162401
ACCESSION NUMBER:		0001213900-25-077488
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20250815
DATE AS OF CHANGE:		20250815

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SenesTech, Inc.
		CENTRAL INDEX KEY:			0001680378
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				202079805
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-289650
		FILM NUMBER:		251224975

	BUSINESS ADDRESS:	
		STREET 1:		777 W. PINNACLE PEAK ROAD
		STREET 2:		SUITE B104
		CITY:			PHOENIX
		STATE:			AZ
		ZIP:			85027
		BUSINESS PHONE:		(928) 779 - 4143

	MAIL ADDRESS:	
		STREET 1:		PO BOX 3627
		CITY:			FLAGSTAFF
		STATE:			AZ
		ZIP:			86003
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>ea0253462-s3_senestech.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the Securities and Exchange Commission
on August 15, 2025</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333- &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM S-3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE SECURITIES ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 25%"></TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 50%; text-align: center"><B>SENESTECH, INC.</B></TD><TD STYLE="text-align: justify; width: 25%">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its
charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>20-2079805</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction
    of</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation or organization)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification Number)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>13430 North Dysart Road, Suite 105</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Surprise, Arizona 85379</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>(928) 779-4143</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B><U></U></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address, including zip code, and telephone number,
including area code, of registrant&rsquo;s principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Joel L. Fruendt</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>President and Chief Executive Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SenesTech, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>13430 North Dysart Road, Suite 105</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Surprise, Arizona 85379</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>(928) 779-4143</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, address, including zip code, and telephone
number, including area code, of agent for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Copies to:</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Brian H. Blaney, Esq.<BR>
Katherine A. Beck, Esq.<BR>
Greenberg Traurig, LLP<BR>
2375 E. Camelback Road, Suite 800<BR>
Phoenix, Arizona 85016<BR>
(602) 445-8000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Approximate date of commencement of proposed
sale to the public:</B> From time to time after the effective date of this registration statement, as determined by market conditions
and other factors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the only securities being registered on this
Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of the securities being registered on
this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities
offered only in connection with dividend or interest reinvestment plans, check the following box. &#9746;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is filed to register additional
securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a registration statement pursuant
to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant
to Rule 462(e) under the Securities Act, check the following box. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment to
a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of
securities pursuant to Rule 413(b) under the Securities Act, check the following box. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company&rdquo;
and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer</FONT></TD>
    <TD STYLE="width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer</FONT></TD>
    <TD STYLE="width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated filer</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting company</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Registrant hereby amends this registration
statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment that
specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities
Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission,
acting pursuant to said Section 8(a), may determine.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Red"><B>The information in
this prospectus is not complete and may be changed. The Selling Stockholders may not sell these securities until the registration statement
filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities, and the Selling
Stockholders are not soliciting offers to buy these securities in any jurisdiction where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Red"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20%; text-align: left"><FONT STYLE="color: Red"><B>PROSPECTUS</B></FONT></TD><TD STYLE="text-align: right; width: 80%"><FONT STYLE="color: Red"><B>SUBJECT
                                            TO COMPLETION, DATED AUGUST 15, 2025</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SenesTech, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2,261,252 Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to this prospectus, the selling stockholders
identified herein (the &ldquo;Selling Stockholders&rdquo;) are offering on a resale basis an aggregate of 2,188,308 shares (the &ldquo;Inducement
Shares&rdquo;) of our common stock, par value $0.001 per share (&ldquo;Common Stock&rdquo;), representing shares issuable upon the exercise
of outstanding warrants to purchase up to 2,188,308 shares of Common Stock with a per share exercise price equal to $5.25 (the &ldquo;Common
Stock Warrants&rdquo;), and 72,944 shares (the &ldquo;Placement Agent Shares,&rdquo; and together with the Inducement Shares, the &ldquo;Shares&rdquo;)
of Common Stock, representing shares issuable upon the exercise of outstanding placement agent warrants to purchase up to 72,944 shares
of Common Stock with a per share exercise price equal to $5.4219 (the &ldquo;Placement Agent Warrants,&rdquo; and together with the Common
Stock Warrants, the &ldquo;Warrants&rdquo;). Upon any cash exercise of the Warrants by the Selling Stockholders, we will receive cash
proceeds per share equal to the exercise price of the Warrants. If the Warrants are exercised in a cashless exercise, we will not receive
any proceeds from the exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Selling Stockholders may sell or otherwise
dispose of the Shares in a number of different ways and at varying prices. We provide more information about how the Selling Stockholders
may sell or otherwise dispose of the Shares in the section entitled &ldquo;Plan of Distribution&rdquo; on page 11. Discounts, concessions,
commissions and similar selling expenses attributable to the sale of the Shares will be borne by the Selling Stockholders. We will pay
all expenses (other than discounts, concessions, commissions and similar selling expenses) relating to the registration of the Shares
with the Securities and Exchange Commission (&ldquo;SEC&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Common Stock is listed on The Nasdaq Capital
Market under the symbol &ldquo;SNES.&rdquo; On August 14, 2025, the last reported sale price for our Common Stock on The Nasdaq Capital
Market was $4.61 per share. Our principal executive offices are located at 13430 North Dysart Road, Suite 105, Surprise, Arizona 85379,
and our telephone number is (928) 779-4143.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus, including such information that
is incorporated by reference, contains summaries of certain provisions contained in some of the documents described herein, but reference
is made to the actual documents for complete information. All the summaries are qualified in their entirety by the actual documents.
Copies of some of the documents referred to herein have been filed or have been incorporated by reference as exhibits to the registration
statement of which this prospectus forms a part, and you may obtain copies of those documents as described in this prospectus under the
heading &ldquo;Where You Can Find Additional Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investing in our securities involves a
high degree of risk. Please read &ldquo;Risk Factors&rdquo; beginning on page 4 of this prospectus as well as any other risk factors
and other information contained in any other document that is incorporated by reference herein.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Neither the SEC nor any state securities commission
has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary
is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>This prospectus is dated &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2025.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 92%"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABOUT THIS PROSPECTUS </B></FONT></A></TD>
    <TD STYLE="width: 8%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORWARD-LOOKING STATEMENTS</B></FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS SUMMARY</B></FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUMMARY OF THE OFFERING</B></FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RISK FACTORS</B></FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>USE OF PROCEEDS</B></FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DILUTION</B></FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION OF PRIVATE PLACEMENT</B></FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLING STOCKHOLDERS</B></FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLAN OF DISTRIBUTION</B></FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LEGAL MATTERS</B></FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXPERTS</B></FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHERE YOU CAN FIND ADDITIONAL INFORMATION</B></FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</B></FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should read this prospectus and the information
incorporated by reference in this prospectus and any applicable prospectus supplement before making an investment in our securities.
Please read &ldquo;Where You Can Find Additional Information&rdquo; for more information. We have not and the Selling Stockholders have
not authorized anyone to provide you with any information or to make any representation, other than those contained in this prospectus
and the documents incorporated by reference or any free writing prospectus we have prepared. We take no responsibility for, and provide
no assurance as to the reliability of, any other information that others may give you. The information contained in this prospectus or
incorporated by reference in this prospectus is accurate only as of its date, or the date of the applicable document incorporated by
reference, regardless of the time of delivery of this prospectus or of any sale of our Common Stock. Our business, financial condition,
results of operations and prospects may have changed since that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For investors outside the United States: We have
not done anything that would permit possession or distribution of this prospectus in any jurisdiction where action for that purpose is
required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform
themselves about, and observe any restrictions relating to, the offering of securities and the distribution of this prospectus outside
the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_001"></A><FONT STYLE="text-transform: uppercase"><B>about
this prospectus</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The registration statement of which this prospectus
forms a part that we have filed with the SEC, utilizing a shelf registration process, includes exhibits that provide more detail of the
matters discussed in this prospectus. Under the shelf registration process, the Selling Stockholders may, from time to time, offer and
sell the Shares described in this prospectus in one or more offerings. Information about the Selling Stockholders may change over time.
You should read this prospectus and the related exhibits filed with the SEC, together with the additional information described under
the headings &ldquo;Where You Can Find Additional Information&rdquo; and &ldquo;Incorporation of Certain Information by Reference&rdquo;
before making your investment decision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should rely only on the information provided
in or incorporated by reference in this prospectus, in any prospectus supplement or in a related free writing prospectus, or documents
to which we otherwise refer you. Neither we nor the Selling Stockholders have authorized anyone else to provide you with different information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither we nor the Selling Stockholders have
authorized any dealer, agent or other person to give any information or to make any representation other than those contained or incorporated
by reference in this prospectus and any accompanying prospectus supplement or any related free writing prospectus. You must not rely
upon any information or representation not contained or incorporated by reference in this prospectus or an accompanying prospectus supplement
or any related free writing prospectus. This prospectus and any accompanying prospectus supplement and any related free writing prospectus,
if any, do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the registered securities
to which they relate, nor do this prospectus and any accompanying prospectus supplement and any related free writing prospectus, if any,
constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful
to make such offer or solicitation in such jurisdiction. You should not assume that the information contained in this prospectus and
any accompanying prospectus supplement and any related free writing prospectus, if any, is accurate on any date subsequent to the date
set forth on the front of such document or that any information we have incorporated by reference is correct on any date subsequent to
the date of the document incorporated by reference, even though this prospectus and any accompanying prospectus supplement and any related
free writing prospectus is delivered or securities are sold on a later date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither we nor the Selling Stockholders have
done anything that would permit this offering or possession or distribution of this prospectus or any free writing prospectus in any
jurisdiction where action for that purpose is required, other than in the United States. You are required to inform yourself about and
to observe any restrictions relating as to this offering and the distribution of this prospectus and any such free writing prospectus
outside the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We further note that the representations, warranties
and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference in this prospectus
were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among
the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such representations,
warranties or covenants were accurate only as of the date when made. Accordingly, such representations, warranties and covenants should
not be relied on as accurately representing the current state of our affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should also read and consider the information
in the documents to which we have referred you under the caption &ldquo;Where You Can Find Additional Information&rdquo; in this prospectus.
In addition, this prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference
is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents.
Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to
the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below under
the heading &ldquo;Where You Can Find Additional Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless the context otherwise requires, references
in this prospectus to &ldquo;SenesTech,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our&rdquo; and &ldquo;our company&rdquo; refer
to SenesTech, Inc., a Delaware corporation. Our registered trademarks currently used in the United States include SenesTech, our logo,
including &ldquo;Sound science. Effective solutions.&rdquo;, and Contrapest. Solely for convenience, trademarks and tradenames referred
to in this prospectus may appear without the &reg; or &trade; symbols, but such references are not intended to indicate in any way that
we will not assert, to the fullest extent under applicable law, our rights, or that the applicable owner will not assert its rights,
to these trademarks and tradenames. We do not intend our use or display of other companies&rsquo; trade names or trademarks to imply
a relationship with, or endorsement or sponsorship of us by, any other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus contains and incorporates by
reference market data and industry statistics and forecasts that are based on our own internal estimates as well as independent industry
publications and other publicly available information. Although we believe these sources are reliable, we do not guarantee the accuracy
or completeness of this information and we have not independently verified this information. Although we are not aware of any misstatements
regarding the market and industry data presented in this prospectus or the documents incorporated herein by reference, these estimates
involve risks and uncertainties and are subject to change based on various factors, including those discussed under the headings &ldquo;Risk
Factors&rdquo; in this prospectus, and under similar headings in the other documents that are incorporated herein by reference. Accordingly,
investors should not place undue reliance on this information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_002"></A>FORWARD-LOOKING
STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The statements contained in this prospectus that
are not historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the &ldquo;Securities
Act&rdquo;), and Section 21E of the Securities Exchange Act of 1934, as amended, (the &ldquo;Exchange Act&rdquo;). All statements other
than statements of historical facts contained or incorporated herein by reference in this prospectus, including statements regarding
our future operating results, future financial position, business strategy, objectives, goals, plans, prospects, markets, and plans and
objectives for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements by terms
such as &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;expects,&rdquo; &ldquo;intends,&rdquo; &ldquo;suggests,&rdquo;
&ldquo;targets,&rdquo; &ldquo;contemplates,&rdquo; &ldquo;projects,&rdquo; &ldquo;predicts,&rdquo; &ldquo;may,&rdquo; &ldquo;might,&rdquo;
&ldquo;plan,&rdquo; &ldquo;would,&rdquo; &ldquo;should,&rdquo; &ldquo;could,&rdquo; &ldquo;can,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue,&rdquo;
&ldquo;objective,&rdquo; or the negative of those terms, or similar expressions intended to identify forward-looking statements. However,
not all forward-looking statements contain these identifying words. Specific forward-looking statements in this prospectus include statements
regarding:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                            belief that there are growing concerns about the environmental and ecological impact of rodenticides
                                            due to secondary exposure and bioaccumulation, including a push for safer and more humane
                                            products as consumer awareness increases;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                            belief that ContraPest targets the reproductive systems of both male and female rats, is
                                            a highly palatable formulation, does not cause illness or changed behavior in rats, and leads
                                            to significant reductions in fertility and rat populations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                            belief that Evolve is a novel soft bait product in the pest control industry that reduces
                                            fertility in both male and female rats, its palatable formulation produces high acceptance
                                            for sustained consumption even when other sought-after food sources are present, and it does
                                            not cause illness in rats, and, therefore, it does not change behavior or result in bait
                                            aversion; </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                            belief that by targeting the reproductive systems of both male and female rats, and with
                                            palatability promoting continued consumption, the use of Evolve can lead to sustained reductions
                                            of the rat population; </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                            expectation that when regulatory and financial conditions permit, we will seek regulatory
                                            approval for additional jurisdictions beyond the United States&#894;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                            intent to use the proceeds from the exercise of any Warrants for cash for general corporate
                                            purposes, which may include research and development expenses, capital expenditures, working
                                            capital and general and administrative expenses, and potential acquisitions of or investments
                                            in businesses, products and technologies that complement our business, although we have no
                                            present commitments or agreements to make any such acquisitions or investments as of the
                                            date of this prospectus; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                            expectation to continue to incur significant expenses and operating losses in the foreseeable
                                            future.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These forward-looking statements are not guarantees
of future performance and involve known and unknown risks, uncertainties and situations that are difficult to predict and that may cause
our own, or our industry&rsquo;s, actual results to be materially different from the future results that are expressed or implied by
these statements. Accordingly, actual results may differ materially from those anticipated or expressed in such statements as a result
of a variety of factors, including those discussed in Item 1A- &ldquo;Risk Factors&rdquo; of Part I of our Annual Report on Form 10-K,
for the year ended December 31, 2024, filed with the SEC on March 13, 2025, and those contained from time to time in our other filings
with the SEC. A number of factors could cause our actual results to differ materially from those indicated by the forward-looking statements.
Such factors include, among others, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
                                            successful commercialization of our products&#894;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">market
                                            acceptance of our products&#894;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                            financial performance, including our ability to fund operations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                            ability to maintain compliance with Nasdaq&rsquo;s continued listing requirements; </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">regulatory
                                            approval and regulation of our products; and </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">other
                                            factors and risks identified from time to time in our filings with the SEC, including this
                                            prospectus.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All forward-looking statements included herein
are based on information available to us as of the date hereof and speak only as of such date. Except as required by law, we undertake
no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements. The forward-looking
statements contained in or incorporated by reference into this prospectus reflect our views as of the date of this prospectus about future
events and are subject to risks, uncertainties, assumptions and changes in circumstances that may cause our actual results, performance
or achievements to differ significantly from those expressed or implied in any forward-looking statement. Although we believe that the
expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future events, results, performance or achievements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_003"></A>PROSPECTUS
SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This summary highlights information contained
in other parts of this prospectus or incorporated by reference into this prospectus from our filings with the SEC, as described later
in the prospectus. Because it is only a summary, it does not contain all of the information that you should consider before investing
in our securities and it is qualified in its entirety by, and should be read in conjunction with, the more detailed information appearing
elsewhere in this prospectus, including the information incorporated by reference in this prospectus. You should read the entire prospectus
and the information incorporated by reference herein carefully, including the sections titled &ldquo;Risk Factors,&rdquo; &ldquo;Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations,&rdquo; our audited financial statements and the related notes,
which are incorporated herein by reference from our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC
on March 13, 2025, and our unaudited financial statements and the related notes, which are incorporated herein by reference from our
Quarterly Reports on Form 10-Q for the three month period ended March 31, 2025 and for the three and six month periods ended June 30,
2025, filed with the SEC on May 8, 2025 and August 8, 2025, respectively. Please read &ldquo;Where You Can Find Additional Information&rdquo;
on page 12 of this prospectus.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Our Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have developed and are commercializing products
for managing animal pest populations through fertility control. Our current products focus on rat and mouse populations and are known
as ContraPest, Evolve Rat and Evolve Mouse.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As far back as we can trace, rodents - and in
particular rats - have been foes to mankind. Rodents pose threats to human and animal health, food security and infrastructure around
the world, and we have spent centuries trying to mitigate the problems associated with these pests. Rodents are known to be reservoir
hosts for at least 60 zoonotic diseases, and the potential transmission of these diseases creates a global risk to public health and
safety as well as agriculture. Through consumption and contamination, rats destroy at least 20% of the global stored food supply every
year. Additionally, rats cause over $27 billion in damage to public and private infrastructure annually in the United States alone by
burrowing beneath foundations and gnawing on electrical wiring, insulation, fire-proofing systems and equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Over the centuries, the most prevalent response
to rodent infestations has been an attempt to eliminate them through the use of lethal tools such as traps and rodenticides. However,
there are growing concerns about the environmental and ecological impact of rodenticides due to secondary exposure and bioaccumulation,
including a push for safer and more humane products as consumer awareness increases. While some of these challenges are of recent concern,
the efficacy of how rodent infestations respond has always been limited by their extraordinary reproductive rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CONTRAPEST. ContraPest&reg;, our initial product,
is a liquid bait, containing the active ingredients 4-vinylcyclohexene diepoxide (&ldquo;VCD&rdquo;) and triptolide. ContraPest, which
targets the reproductive systems of both male and female rats, is a highly palatable formulation, does not cause illness or changed behavior
in rats, and leads to significant reductions in fertility and rat populations. Accordingly, ContraPest is an additional tool to use as
part of an integrated pest management program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2016, the Environmental Protection
Agency (&ldquo;EPA&rdquo;) granted an unconditional registration for ContraPest as a Restricted Use Product (&ldquo;RUP&rdquo;), requiring
purchase or application oversight by a licensed professional. In October 2018, the EPA approved the removal of the RUP designation and
ContraPest was reclassified as a general-use pesticide. To date, ContraPest is registered in all 50 states (49 states and the District
of Columbia have approved the RUP designation) and two major U.S. territories, Puerto Rico and the U.S. Virgin Islands. On March 10,
2022, the EPA granted a sub-label for ContraPest allowing for an alternative delivery system in a hanging bait station. This sub-label
is marketed as Elevate Bait System&trade; and was designed to target roof rat habitats and infestations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">EVOLVE. The Evolve product line, which began
in the form of Evolve Rat, launched in January 2024, and is currently our lead product. Evolve Rat is a soft bait product that is novel
to the pest control industry and contains the active ingredient, cottonseed oil. Evolve Rat reduces fertility in both male and female
rats. Additionally, its palatable formulation produces high acceptance for sustained consumption even when other sought-after food sources
are present. Evolve Rat does not cause illness in rats and, therefore, it does not change behavior or result in bait aversion. By targeting
the reproductive systems of both male and female rats, and with palatability promoting continued consumption, the use of Evolve can lead
to sustained reductions of the rat population.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Evolve Rat meets the EPA&rsquo;s minimum risk
pesticide conditions under the Federal Insecticide Fungicide and Rodenticide ACT (&ldquo;FIFRA&rdquo;), Section 25(b). Due to its classification,
Evolve Rat is exempt from federal registration because it poses little to no risk to human health and the environment. Evolve Rat may
also be used in agricultural application, as it is made from food ingredients with tolerance exemptions for both food and nonfood applications.
There are 10 states that accept the federal exemption for pesticide registration and require no additional determination or approval.
In states that do not accept the federal exemption, we must obtain registration from the various state regulatory agencies. To date,
we are authorized to sell Evolve Rat in 48 states and territories.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2024, we launched Evolve Mouse, our latest
iteration of the Evolve product line. Evolve Mouse is a variation of our soft bait formulation and contains the active ingredient, cottonseed
oil, in a different concentration. Evolve Mouse limits reproduction of male and female mice and is also considered a minimum risk pesticide
under the EPA&rsquo;s FIFRA, Section 25(b). To date, we are authorized to sell Evolve Mouse in 37 states.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are continuously enhancing ContraPest and
Evolve to align with the unique needs and environments of our customers in our target verticals, while simultaneously pursuing regulatory
approvals and amendments to our existing U.S. registrations to broaden its use and marketability. When regulatory and financial conditions
permit, we will seek regulatory approval for additional jurisdictions beyond the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For a complete description of our business, financial
condition, results of operations and other important information, please read our filings with the SEC that are incorporated by reference
in this prospectus, including our Annual Report on Form 10-K for the year ended December 31, 2024. For instructions on how to find copies
of these documents, please read &ldquo;Where You Can Find Additional Information&rdquo; and &ldquo;Incorporation of Certain Information
by Reference.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Recent Developments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Warrant Inducement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 4, 2025, we entered into inducement
offer letter agreements (the &ldquo;Inducement Letters&rdquo;) with certain holders (the &ldquo;Holders&rdquo;) of certain of our existing
warrants to purchase up to 1,458,872 shares of our Common Stock, originally issued to the Holders on July 1, 2025, at an exercise price
of $4.15 per share (the &ldquo;Existing Warrants&rdquo;). Pursuant to the Inducement Letters, the Holders agreed to exercise for cash
their Existing Warrants to purchase an aggregate of 1,458,872 shares of Common Stock at the existing exercise price of $4.15 per share
and pay a purchase price of $0.125 per share, or an aggregate purchase price of $273,538.50, in consideration of our agreement to issue,
in a private placement, new&nbsp;short-term Common Stock Warrants to purchase up to an aggregate of 2,188,308 shares of Common Stock
at an exercise price of $5.25 per share (the &ldquo;Warrant Inducement&rdquo;).The Common Stock Warrants are exercisable commencing on
the Closing Date (as defined below) and expire on the fifteen-month anniversary of the effective date of the registration statement of
which this prospectus forms a part. The closing of the transactions contemplated pursuant to the Inducement Letters occurred on August
5, 2025 (the &ldquo;Closing Date&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We engaged H.C. Wainwright
&amp; Co., LLC (&ldquo;Wainwright&rdquo;) to act as our exclusive placement agent in connection with the Warrant Inducement. We also
agreed to issue to Wainwright or its designees Placement Agent Warrants to purchase up to 72,944 shares of Common Stock (representing
5% of the Existing Warrants being exercised), which Placement Agent Warrants have the same terms as the Common Stock Warrants except
that the Placement Agent Warrants have an exercise price equal to $5.4219 per share (125% of the offering price). The Placement Agent
Warrants are exercisable commencing on the Closing Date and expire on the fifteen-month anniversary of the effective date of the registration
statement of which this prospectus forms a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Warrant Inducement, we
also agreed to file the registration statement of which this prospectus forms a part providing for the resale of the Shares issued or
issuable upon the exercise of the Warrants, as soon as practicable (and in any event within 15 calendar days of the date of the Inducement
Letters), and to use commercially reasonable efforts to have such registration statement declared effective by the SEC within 60 calendar
days following the date of the Inducement Letters (or within 90 calendar days following the date of the Inducement Letters in case of
a &ldquo;full review&rdquo; of such registration statement by the SEC) and to keep the registration statement effective at all times
until no holder of the Warrants owns any Warrants or Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Corporate and Other Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We were incorporated in Nevada in July 2004 and
reincorporated in Delaware in November 2015. Our principal executive offices are located at 13430 North Dysart Road, Suite 105, Surprise,
Arizona 85379, and our telephone number is (928) 779-4143. Our corporate website address is <I>www.senestech.com</I>. The information
contained on or accessible through our website is not a part of this prospectus and should not be relied upon in connection with making
an investment decision.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="a_004"></A>SUMMARY OF THE OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Selling Stockholders
identified in this prospectus are offering on a resale basis an aggregate of 2,261,252 shares of Common Stock issuable upon the exercise
of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify; text-indent: -3in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 38%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Securities
    Offered by the Selling Stockholders</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up to 2,261,252
    shares of our Common Stock, par value $0.001 per share, consisting of (i) 2,188,308 shares of our Common Stock issuable upon the
    exercise of the Common Stock Warrants, and (ii) 72,944 shares of our Common Stock issuable upon the exercise of the Placement Agent
    Warrants.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use of Proceeds</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will not receive any
    of the proceeds from the sale of the Shares covered by this prospectus, except with respect to amounts received by us due to the
    exercise of any Warrants for cash. We intend to use the proceeds from the exercise of any Warrants for cash for general corporate
    purposes, which may include research and development expenses, capital expenditures, working capital and general and administrative
    expenses, and potential acquisitions of or investments in businesses, products and technologies that complement our business, although
    we have no present commitments or agreements to make any such acquisitions or investments as of the date of this prospectus. See
    &ldquo;Use of Proceeds.&rdquo;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk Factors</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You should carefully read
    and consider the information set forth under &ldquo;Risk Factors&rdquo; on page 4  of this prospectus and under similar headings in
    the documents incorporated by reference herein before deciding to invest in our securities.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Market for Common Stock</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Common Stock is listed on The Nasdaq Capital Market
    under the symbol &ldquo;SNES.&rdquo;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify; text-indent: -3in"><B>&nbsp;</B></P>

</DIV>
<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_005"></A>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investing in our securities, including our Common
Stock, involves a number of risks. You should not invest unless you are able to bear the complete loss of your investment. You should
carefully consider the risks described below and discussed under the section entitled &ldquo;Risk Factors&rdquo; in our most recent Annual
Report on Form 10-K, which is incorporated herein by reference, together with other information in this prospectus and the information
and documents incorporated by reference in this prospectus, including our future reports on Form 10-K and 10-Q. For a description of
these reports and documents, and information about where you can find them, see &ldquo;Where You Can Find More Information&rdquo; and
&ldquo;Incorporation of Certain Documents by Reference.&rdquo; The risks and uncertainties we have described below and under the section
entitled &ldquo;Risk Factors&rdquo; in our most recent Annual Report on Form 10-K incorporated herein by reference are not the only risks
and uncertainties we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may
impair our business operations. If any of the risks actually occur, our business could be harmed. In such case, the trading price of
our Common Stock could decline and investors could lose all or a part of the money paid to buy our securities. Our actual results could
differ materially from those anticipated in these forward-looking statements as a result of these and other factors. See also the statements
contained under the heading &ldquo;Forward-Looking Statements.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business is subject to a number of risks,
including risks that may prevent us from achieving our business objectives or may adversely affect our business, results of operations,
financial condition and prospects. These risks are discussed more fully below and include risks related to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to this Offering </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If we are unable to continue as a going
concern, our securities will have little or no value.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have incurred operating losses since our inception,
and we expect to continue to incur significant expenses and operating losses for the foreseeable future. Our financial statements as
of December 31, 2024 and 2023 have been prepared under the assumption that we will continue as a going concern. Our independent registered
public accounting firm included in its opinion for the years ended December&nbsp;31, 2024 and 2023 an explanatory paragraph referring
to our net loss from operations and net capital deficiency and expressing substantial doubt in our ability to continue as a going concern
without additional capital becoming available. If we encounter continued issues or delays in the commercialization of our products or
greater than anticipated expenses, our prior losses and expected future losses could have an adverse effect on our financial condition
and negatively impact our ability to fund continued operations, obtain additional financing in the future and continue as a going concern.
There are no assurances that such financing, if necessary, will be available to us at all or will be available in sufficient amounts
or on reasonable terms. Our financial statements do not include any adjustments that may result from the outcome of this uncertainty.
If we are unable to generate additional funds in the future through financings, sales of our products, licensing fees, royalty payments
or from other sources or transactions, we will exhaust our resources and will be unable to continue operations. If we cannot continue
as a going concern, our stockholders would likely lose most or all of their investment in us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>The sale of a
substantial amount of our shares of Common Stock, including resale of the Shares being registered hereunder, in the public market could
adversely affect the prevailing market price of our Common Stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We are registering for
resale 2,261,252 shares of Common Stock. Sales of substantial amounts of shares of our Common Stock in the public market, or the perception
that such sales might occur, could adversely affect the market price of our shares of Common Stock, and the market value of our other
securities. We cannot predict if and when the Selling Stockholders may sell such Shares in the public markets. Furthermore, in the future,
we may issue additional shares of Common Stock or other equity or debt securities convertible into shares of Common Stock. Any such issuance
could result in substantial dilution to our existing shareholders and could cause our stock price to decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We do not intend to pay any cash dividends
on Common Stock in the foreseeable future and, therefore, any return on your investment in Common Stock must come from increases in the
fair market value and trading price of Common Stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not intend to pay any cash dividends on
Common Stock in the foreseeable future and, therefore, any return on your investment in Common Stock must come from increases in the
fair market value and trading price of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_006"></A>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are registering the Shares for resale by the
Selling Stockholders. We will not receive any of the proceeds from the sale of the Shares covered by this prospectus, except with respect
to amounts received by us due to the exercise of any Warrants for cash. If the Warrants are exercised in a cashless exercise, we will
not receive any proceeds from the exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We intend to use the proceeds from the exercise
of any Warrants for cash for general corporate purposes, which may include research and development expenses, capital expenditures, working
capital and general and administrative expenses, and potential acquisitions of or investments in businesses, products and technologies
that complement our business, although we have no present commitments or agreements to make any such acquisitions or investments as of
the date of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_007"></A>Dilution</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This offering of the Shares by the Selling Stockholders
on a continuous or delayed basis in the future will not result in a change to the net tangible book value per share before and after
the distribution of the Shares by the Selling Stockholders. However, purchasers of the Shares from the Selling Stockholders will experience
dilution to the extent of the difference between the amount per share paid and the net tangible book value per share of our Common Stock
at the time of the purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_008"></A>DESCRIPTION OF PRIVATE PLACEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 4, 2025, we entered into the Inducement
Letters with the Holders of the Existing Warrants to purchase up to 1,458,872 shares of our Common Stock, originally issued to the Holders
on July 1, 2025, at an exercise price of $4.15 per share. Pursuant to the Inducement Letters, the Holders agreed to exercise for cash
their Existing Warrants to purchase an aggregate of 1,458,872 shares of Common Stock at the existing exercise price of $4.15 per share
and pay a purchase price of $0.125 per share, or an aggregate purchase price of $273,538.50 in consideration of our agreement to issue,
in a private placement, new&nbsp;short-term Common Stock Warrants to purchase up to an aggregate of 2,188,308 shares of Common Stock
at an exercise price of $5.25 per share. The Common Stock Warrants are exercisable commencing on the Closing Date and expire on the fifteen-month
anniversary of the effective date of the registration statement of which this prospectus forms a part. The closing of the transactions
contemplated pursuant to the Inducement Letters occurred on August 5, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We engaged Wainwright to act as our exclusive
placement agent in connection with the Warrant Inducement. We also agreed to issue to the Wainwright or its designees Placement Agent
Warrants to purchase up to 72,944 shares of Common Stock (representing 5% of the Existing Warrants being exercised), which have the same
terms as the Common Stock Warrants except the Placement Agent Warrants have an exercise price equal to $5.4219 per share (125% of the
offering price). The Placement Agent Warrants are exercisable commencing on the Closing Date and expire on the fifteen-month anniversary
of the effective date of the registration statement of which this prospectus forms a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Warrant Inducement, we
also agreed to file the registration statement of which this prospectus forms a part providing for the resale of the Shares issued or
issuable upon the exercise of the Warrants, as soon as practicable (and in any event within 15 calendar days of the date of the Inducement
Letters), and to use commercially reasonable efforts to have such registration statement declared effective by the SEC within 60 calendar
days following the date of the Inducement Letters (or within 90 calendar days following the date of the Inducement Letters in case of
a &ldquo;full review&rdquo; of such registration statement by the SEC) and to keep the registration statement effective at all times
until no holder of the Warrants owns any Warrants or Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_009"></A>SELLING STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have prepared this prospectus to allow the
Selling Stockholders to offer for resale, from time to time, 2,261,252 Shares issuable upon the exercise of the Warrants. The Selling
Stockholders acquired the Warrants in connection with the Inducement Letters and related transactions, and we are filing the registration
statement of which this prospectus is a part pursuant to the Inducement Letters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not know how long the Selling Stockholders
will hold the Warrants, whether the Selling Stockholders will exercise the Warrants, and upon such exercise, how long such Selling Stockholders
will hold the Shares before selling them, and we currently have no agreements, arrangements or understandings with the Selling Stockholders
regarding the sale of any of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents information regarding
the Selling Stockholders and the Shares that they may offer and sell from time to time under this prospectus. The table is prepared based
on information supplied to us by the Selling Stockholders and reflects their holdings as of August 14, 2025, unless otherwise noted in
the footnotes to the table. Beneficial ownership is determined in accordance with the rules of the SEC, and thus represents voting or
investment power with respect to our securities. Under such rules, beneficial ownership includes any shares over which the Selling Stockholders
have sole or shared voting power or investment power as well as any shares the Selling Stockholders have the right to acquire within
60 days after the date of this table, including the Warrants. Unless otherwise indicated below, to our knowledge and subject to applicable
community property rules, the Selling Stockholders named in the table have sole voting and sole investment power with respect to all
equity interests beneficially owned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name of Selling Stockholder</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of<BR> Shares of<BR> Common Stock<BR> Beneficially Owned Prior to<BR> Offering<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum Number<BR> of Shares of<BR> Common Stock to<BR> be Sold Pursuant<BR> to this Prospectus<SUP>(2)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of<BR> Shares of<BR> Common Stock<BR> Beneficially Owned After<BR> Offering<SUP>(3)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage of<BR> Beneficial<BR> Ownership<BR> After Offering<SUP>(4)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lind Global Fund II, LP<SUP>(5)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,558,546</TD><TD STYLE="width: 1%; text-align: left"><SUP>(6)</SUP></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">782,616</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">775,930</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">4.99</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sabby Volatility Warrant Master Fund, Ltd.<SUP>(7)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,391,865</TD><TD STYLE="text-align: left"><SUP>(8)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,119,516</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">272,349</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.78</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PFS Trust<SUP>(9)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">390,000</TD><TD STYLE="text-align: left"><SUP>(10)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">300,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.16</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Glenbrook Capital Management Inc. Employee Profit-Sharing Plan<SUP>(11)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">190,000</TD><TD STYLE="text-align: left"><SUP>(12)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.39</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intracoastal Capital, LLC<SUP>(13)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">47,481</TD><TD STYLE="text-align: left"><SUP>(14)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">46,176</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,305</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KBB Asset Management<SUP>(15)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,000</TD><TD STYLE="text-align: left"><SUP>(16)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael Vasinkevich<SUP>(17)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">142,119</TD><TD STYLE="text-align: left"><SUP>(18)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">46,775</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">95,344</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.31</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noam Rubinstein<SUP>(17)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">69,815</TD><TD STYLE="text-align: left"><SUP>(19)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,977</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">46,838</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Craig Schwabe<SUP>(17)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,480</TD><TD STYLE="text-align: left"><SUP>(20)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,462</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,018</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles Worthman<SUP>(17)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,219</TD><TD STYLE="text-align: left"><SUP>(21)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">730</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,489</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in; text-align: left">*</TD><TD STYLE="text-align: justify">Less than 1%.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in">(1)</TD><TD STYLE="text-align: justify">Consists of shares of Common Stock and shares
                                            of Common Stock issuable pursuant to the full exercise of the Warrants issued in the Warrant
                                            Inducement and other warrants previously acquired from us.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in">(2)</TD><TD STYLE="text-align: justify">Represents shares of Common Stock underlying
                                            the Warrants issued to the Selling Stockholders in the Warrant Inducement. All of the Warrants
                                            that are exercisable for the Shares offered hereby contain certain beneficial ownership limitations,
                                            which provide that a holder of the Warrants will not have the right to exercise any portion
                                            of its Warrants if such holder, together with its affiliates and attribution parties, would
                                            beneficially own in excess of 4.99% of the number of shares of Common Stock outstanding immediately
                                            after giving effect to such exercise, provided that upon at least 61 days prior notice to
                                            us, a holder may increase or decrease such limitation up to a maximum of 9.99% of the number
                                            of shares of Common Stock outstanding (each such limitation, a &ldquo;Beneficial Ownership
                                            Limitation&rdquo;).</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in">(3)</TD><TD STYLE="text-align: justify">Assumes all Shares offered by the Selling
                                            Stockholders hereby are sold and that the Selling Stockholders buy or sell no additional
                                            shares of Common Stock prior to the completion of this offering. We do not know when or in
                                            what amounts the Selling Stockholder may offer Shares for sale. The Selling Stockholder might
                                            not sell any or might sell all of the Shares offered by this prospectus. Because the Selling
                                            Stockholder may offer all or some of the Shares pursuant to this offering, and because there
                                            are currently no agreements, arrangements or understandings with respect to the sale of any
                                            of the Shares, we cannot estimate the number of the Shares that will be held by the Selling
                                            Stockholder after completion of the offering. However, for purposes of this table, we have
                                            assumed that, after completion of the offering, none of the Shares covered by this prospectus
                                            will be held by the Selling Stockholders, including Common Stock issuable upon exercise of
                                            the Warrants issued in the Warrant Inducement.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in">(4)</TD><TD STYLE="text-align: justify">Based on 7,204,373 shares of Common Stock,
                                            consisting of 4,943,121 shares of Common Stock outstanding as of August 14, 2025, and 2,261,252
                                            Shares underlying the Warrants (assuming the full exercise of the Warrants), and excluding
                                            279,894 shares of Common Stock currently held in abeyance.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in">(5)</TD><TD STYLE="text-align: justify">The Common Stock and other securities are
                                            held by Lind Global Fund II, LP. Each of Lind Global Fund II, LP, Lind Global Partners II
                                            LLC and Jeff Easton has sole shared voting and dispositive power over the shares. The address
                                            of Lind Global Fund is c/o The Lind Partners, 444 Madison Ave, 41<SUP>st</SUP> Floor, New
                                            York, New York 10022. We do not have a material relationship with the Selling Stockholder
                                            other than as a result of the ownership of our Common Stock or other securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in">(6)</TD><TD STYLE="text-align: justify">Consists of (i) 211,976 shares of Common
                                            Stock; and (ii) 1,346,570 shares of Common Stock issuable upon the exercise of outstanding
                                            warrants, including 782,616 Shares issuable upon the exercise of the Warrants issued in connection
                                            with the Warrant Inducement and being registered for resale pursuant to the registration
                                            statement of which this prospectus forms a part, and excludes 279,894 shares of Common Stock
                                            currently held in abeyance. The Selling Stockholder&rsquo;s warrants prohibit the exercise
                                            of such warrants if, after giving effect to such exercise, it would result in the Selling
                                            Stockholder&rsquo;s, including any person or entity whose beneficial ownership would be attributable
                                            to the Selling Stockholder, beneficial ownership exceeding the applicable Beneficial Ownership
                                            Limitation.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in">(7)</TD><TD STYLE="text-align: justify">The Common Stock and other securities are
                                            held by Sabby Volatility Warrant Master Fund, Ltd. (&ldquo;Sabby&rdquo;). Sabby Management,
                                            LLC, the investment manager to Sabby, has discretionary authority to vote and dispose of
                                            the shares held by Sabby and may be deemed to be the beneficial owner of these shares. Hal
                                            Mintz (&ldquo;Mr. Mintz&rdquo;), in his capacity as manager of Sabby Management, LLC, may
                                            also be deemed to have investment discretion and voting power over the shares held by Sabby.
                                            Sabby Management, LLC and Mr. Mintz each disclaim any beneficial ownership of these shares.
                                            The address of Sabby Volatility Warrant Master Fund, Ltd. is c/o Captiva (Cayman) Ltd, Governors
                                            Square, Bldg 4, 2<SUP>nd</SUP> Floor, 23 Lime Tree Bay Avenue, P.O. Box 32315, Grand Cayman
                                            KY1-1209, Cayman Islands. We do not have a material relationship with the Selling Stockholder
                                            other than as a result of the ownership of our Common Stock or other securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in">(8)</TD><TD STYLE="text-align: justify">Consists of (i) 272,349 shares of Common
                                            Stock; and (ii) 1,119,516 shares of Common Stock issuable upon the exercise of the Warrants
                                            issued in connection with the Warrant Inducement and being registered for resale pursuant
                                            to the registration statement of which this prospectus forms a part. The Selling Stockholder&rsquo;s
                                            warrants prohibit the exercise of such warrants if, after giving effect to such exercise,
                                            it would result in the Selling Stockholder&rsquo;s, including any person or entity whose
                                            beneficial ownership would be attributable to the Selling Stockholder, beneficial ownership
                                            exceeding the applicable Beneficial Ownership Limitation.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in">(9)</TD><TD STYLE="text-align: justify">The Common Stock and other securities are
                                            held by PFS Trust. Each of Grover T. Wickersham and Richard Rudgley holds sole shared voting
                                            and dispositive power and disclaims beneficial ownership. The address of PFS Trust is 2207,
                                            Suite B, Bellanca St., Minden, Nevada 89423. We do not have a material relationship with
                                            the Selling Stockholder other than as a result of the ownership of our Common Stock or other
                                            securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in">(10)</TD><TD STYLE="text-align: justify">Consists of (i) 300,000 shares of Common Stock;
                                            and (ii) 90,000 Shares issuable upon the exercise of the Warrants issued in connection
                                            with the Warrant Inducement and being registered for resale pursuant to the registration
                                            statement of which this prospectus forms a part. The Selling Stockholder&rsquo;s warrants
                                            prohibit the exercise of such warrants if, after giving effect to such exercise, it would
                                            result in the Selling Stockholder&rsquo;s, including any person or entity whose beneficial
                                            ownership would be attributable to the Selling Stockholder, beneficial ownership exceeding
                                            the applicable Beneficial Ownership Limitation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in; text-align: left">(11)</TD><TD STYLE="text-align: justify">The Common Stock and
                                            other securities are held by Glenbrook Capital Management Inc. Employee Profit-Sharing Plan
                                            (&ldquo;Glenbrook&rdquo;). Each of Grover T. Wickersham and Richard Rudgley holds sole shared
                                            voting and dispositive power and disclaims beneficial ownership. The address of Glenbrook
                                            is 5396 Avenue 18 &frac12;, Chowchilla, CA 93610. We do not have a material relationship
                                            with the Selling Stockholder other than as a result of the ownership of our Common Stock
                                            or other securities.</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in; text-align: left">(12)</TD><TD STYLE="text-align: justify">Consists of (i) 100,000
                                            shares of Common Stock; and (ii) 90,000 Shares issuable upon the exercise of the Warrants
                                            issued in connection with the Warrant Inducement and being registered for resale pursuant
                                            to the registration statement of which this prospectus forms a part. The Selling Stockholder&rsquo;s
                                            warrants prohibit the exercise of such warrants if, after giving effect to such exercise,
                                            it would result in the Selling Stockholder&rsquo;s, including any person or entity whose
                                            beneficial ownership would be attributable to the Selling Stockholder, beneficial ownership
                                            exceeding the applicable Beneficial Ownership Limitation.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in">(13)</TD><TD STYLE="text-align: justify">The Common Stock and other securities are
                                            held by Intracoastal Capital, LLC. Michael P. Kopin (&ldquo;Mr. Kopin&rdquo;) and Daniel
                                            B. Asher (&ldquo;Mr. Asher&rdquo;), each of whom are managers of Intracoastal Capital, LLC
                                            (&ldquo;Intracoastal&rdquo;), have shared voting control and investment discretion over the
                                            securities reported herein that are held by Intracoastal. As a result, each of Mr. Kopin
                                            and Mr. Asher may be deemed to have beneficial ownership (as determined under Section 13(d)
                                            of the Exchange Act) of the securities reported herein that are held by Intracoastal. The
                                            address of Intracoastal Capital, LLC is 245 Palm Trail, Delray Beach, Florida 33483. We do
                                            not have a material relationship with the Selling Stockholder other than as a result of the
                                            ownership of our Common Stock or other securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in; text-align: left">(14)</TD><TD STYLE="text-align: justify">Consists of 47,481 shares
                                            of Common Stock issuable upon the exercise of outstanding warrants, including 46,176 Shares
                                            issuable upon the exercise of the Warrants issued in connection with the Warrant Inducement
                                            and being registered for resale pursuant to the registration statement of which this prospectus
                                            forms a part. The Selling Stockholder&rsquo;s warrants prohibit the exercise of such warrants
                                            if, after giving effect to such exercise, it would result in the Selling Stockholder&rsquo;s,
                                            including any person or entity whose beneficial ownership would be attributable to the Selling
                                            Stockholder, beneficial ownership exceeding the applicable Beneficial Ownership Limitation.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in">(15)</TD><TD STYLE="text-align: justify">The securities are held by KBB Asset Management.
                                            The address of KBB Asset Management is 47 Calle Del Sur, Palm Coast, Florida 32137. We do
                                            not have a material relationship with the Selling Stockholder other than as a result of the
                                            ownership of our Common Stock or other securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in">(16)</TD><TD STYLE="text-align: justify">Consists of 60,000 Shares issuable upon
                                            the exercise of the Warrants issued in connection with the Warrant Inducement and being registered
                                            for resale pursuant to the registration statement of which this prospectus forms a part.
                                            The Selling Stockholder&rsquo;s warrants prohibit the exercise of such warrants if, after
                                            giving effect to such exercise, it would result in the Selling Stockholder&rsquo;s, including
                                            any person or entity whose beneficial ownership would be attributable to the Selling Stockholder,
                                            beneficial ownership exceeding the applicable Beneficial Ownership Limitation.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in">(17)</TD><TD STYLE="text-align: justify">The Selling Stockholder is affiliated with
                                            Wainwright, a registered broker-dealer with a registered address of H.C. Wainwright &amp;
                                            Co., LLC, 430 Park Ave, 3rd Floor, New York, NY 10022. Wainwright acted as our placement
                                            agent in the Warrant Inducement. The Selling Stockholder has sole voting and dispositive
                                            power over the securities held, acquired the securities in the ordinary course of business
                                            and, at the time the securities were acquired, the Selling Stockholder had no agreement or
                                            understanding, directly or indirectly, with any person to distribute such securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in">(18)</TD><TD STYLE="text-align: justify">Consists of 142,119 shares of Common Stock
                                            issuable upon the exercise of outstanding warrants, including 46,775 Shares issuable upon
                                            the exercise of the Warrants issued as compensation in connection with the Warrant Inducement
                                            and being registered for resale pursuant to the registration statement of which this prospectus
                                            forms a part. The Selling Stockholder&rsquo;s warrants prohibit the exercise of such warrants
                                            if, after giving effect to such exercise, it would result in the Selling Stockholder&rsquo;s,
                                            including any person or entity whose beneficial ownership would be attributable to the Selling
                                            Stockholder, beneficial ownership exceeding the applicable Beneficial Ownership Limitation.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in">(19)</TD><TD STYLE="text-align: justify">Consists of 69,815 shares of Common Stock
                                            issuable upon the exercise of outstanding warrants, including 22,977 Shares issuable upon
                                            the exercise of the Warrants issued as compensation in connection with Warrant Inducement
                                            and being registered for resale pursuant to the registration statement of which this prospectus
                                            forms a part. The Selling Stockholder&rsquo;s warrants prohibit the exercise of such warrants
                                            if, after giving effect to such exercise, it would result in the Selling Stockholder&rsquo;s,
                                            including any person or entity whose beneficial ownership would be attributable to the Selling
                                            Stockholder, beneficial ownership exceeding the applicable Beneficial Ownership Limitation.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in">(20)</TD><TD STYLE="text-align: justify">Consists of 7,480 shares of Common Stock
                                            issuable upon the exercise of outstanding warrants, including 2,462 Shares issuable upon
                                            the exercise of the Warrants issued as compensation in connection with the Warrant Inducement
                                            and being registered for resale pursuant to the registration statement of which this prospectus
                                            forms a part. The Selling Stockholder&rsquo;s warrants prohibit the exercise of such warrants
                                            if, after giving effect to such exercise, it would result in the Selling Stockholder&rsquo;s,
                                            including any person or entity whose beneficial ownership would be attributable to the Selling
                                            Stockholder, beneficial ownership exceeding the applicable Beneficial Ownership Limitation.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.35in">(21)</TD><TD STYLE="text-align: justify">Consists of 2,219 shares of Common Stock
                                            issuable upon the exercise of outstanding warrants, including 730 Shares issuable upon the
                                            exercise of the Warrants issued as compensation in connection with the Warrant Inducement
                                            and being registered for resale pursuant to the registration statement of which this prospectus
                                            forms a part. The Selling Stockholder&rsquo;s warrants prohibit the exercise of such warrants
                                            if, after giving effect to such exercise, it would result in the Selling Stockholder&rsquo;s,
                                            including any person or entity whose beneficial ownership would be attributable to the Selling
                                            Stockholder, beneficial ownership exceeding the applicable Beneficial Ownership Limitation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_010"></A>PLAN
OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Selling Stockholders and any of their pledges,
assignees and successors-in-interest may, from time to time, sell any or all of their Shares covered hereby on the principal trading
market or any other stock exchange, market or trading facility on which the Shares are traded or in private transactions. These sales
may be at fixed or negotiated prices. The Selling Stockholders may use any one or more of the following methods when selling the Shares:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ordinary
                                            brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">block
                                            trades in which the broker-dealer will attempt to sell the Shares as agent, but may position
                                            and resell a portion of the block as principal to facilitate the transaction;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">purchases
                                            by a broker-dealer as principal and resale by the broker-dealer for its own account;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">an
                                            exchange distribution in accordance with the rules of the applicable exchange;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">privately
                                            negotiated transactions;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">short
                                            sales effected after the date the registration statement of which this prospectus is a part
                                            is declared effective by the SEC;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">through
                                            the writing or settlement of options or other hedging transactions, whether through an options
                                            exchange or otherwise;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">through
                                            agreements between broker-dealers and the seller stockholder(s) to sell a specified number
                                            of such Shares at a stipulated price per share;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">a
                                            combination of any such methods of sale; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any
                                            other method permitted by applicable law.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Selling Stockholders may also sell the Shares
under Rule 144 or any other exemption from registration under the Securities Act, if available, rather than under this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Broker-dealers engaged by the Selling Stockholders
may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the Selling Stockholders
(or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except
as set forth in a supplement to this prospectus, in the case of an agency transaction not in excess of a customary brokerage commission
in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in compliance with FINRA Rule 2121.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the sale of the Shares or
interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial institutions,
which may in turn engage in short sales of the Shares in the course of hedging the positions they assume. The Selling Stockholders may
also sell the Shares short and deliver the Shares to close out their short positions, or loan or pledge the securities to broker-dealers
that in turn may sell the Shares. The Selling Stockholders may also enter into option or other transactions with broker-dealers or other
financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other financial
institution of the Shares offered by this prospectus, which Shares such broker-dealer or other financial institution may resell pursuant
to this prospectus (as supplemented or amended to reflect such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Selling Stockholders and any broker-dealers
or agents that are involved in selling the Shares may be deemed to be &ldquo;underwriters&rdquo; within the meaning of the Securities
Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale
of the Shares purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. The Selling Stockholders
have informed us that they do not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute
the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We agreed to keep this prospectus effective until
the Selling Stockholders no longer own any Warrants and all of the Shares have been sold pursuant to this prospectus or Rule 144 under
the Securities Act or any other rule of similar effect. The Shares will be sold only through registered or licensed brokers or dealers
if required under applicable state securities laws. In addition, in certain states, the Shares covered hereby may not be sold unless
they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement
is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under applicable rules and regulations under
the Exchange Act, any person engaged in the distribution of the resale Shares may not simultaneously engage in market making activities
with respect to the Common Stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution.
In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder,
including Regulation M, which may limit the timing of purchases and sales of the Common Stock by the Selling Stockholders or any other
person. We will make copies of this prospectus available to the Selling Stockholders and have informed it of the need to deliver a copy
of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities
Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_011"></A>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The validity of the Shares being offered hereby
will be passed upon for us by Greenberg Traurig, LLP, Phoenix, Arizona.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_012"></A>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The financial statements of our company as of
December 31, 2024 and 2023, and for each of the two years in the period ended December 31, 2024, incorporated by reference in this prospectus
have been so incorporated in reliance on the report of M&amp;K CPAS, PLLC, an independent registered public accounting firm (which report
contains an explanatory paragraph describing conditions that raise substantial doubt about our ability to continue as a&nbsp;going&nbsp;concern,&nbsp;as
described in Note 1 to the financial statements), given on the authority of said firm as experts in auditing and accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_013"></A>WHERE
YOU CAN FIND ADDITIONAL INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We file annual, quarterly and current reports,
proxy statements and other information with the SEC. The SEC maintains a website that contains reports, proxy and information statements
and other information regarding companies, such as ours, that file documents electronically with the SEC. The website address is <I>www.sec.gov</I>.
The information on the SEC&rsquo;s website is not part of this prospectus, and any references to this website or any other website are
inactive textual references only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_014"></A>INCORPORATION
</B></FONT><B>OF CERTAIN INFORMATION BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We &ldquo;incorporate by reference&rdquo; certain
information into this registration statement, which means that we disclose important information to you by referring you to another document
filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus, and relying on the
Fixing America&rsquo;s Surface Transportation Act, or the FAST Act, as a smaller reporting company, subsequent information that we file
with the SEC will automatically update and supersede that information. Any statement contained in a previously filed document incorporated
by reference will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in
this prospectus modifies or replaces that statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We incorporate by reference our documents listed
below and any future filings made by us with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the termination
of the offering, including documents we may file with the SEC after the date of the initial registration statement and prior to effectiveness
of the registration statement. We are not, however, incorporating by reference any documents or portions thereof, whether specifically
listed below or filed in the future, that are not deemed &ldquo;filed&rdquo; with the SEC, including any information furnished pursuant
to Items 2.02 or 7.01 of Form 8-K or related exhibits furnished pursuant to Item 9.01 of Form 8-K. This prospectus and any amendments
or supplements thereto incorporate by reference the documents set forth below that have previously been filed with the SEC:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
                                            Annual Report on <A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000162828025012408/snes-20241231.htm">Form 10-K</A> for the fiscal year ended December 31, 2024, filed with the SEC
                                            on March 13, 2025.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
                                            Definitive Proxy Statement on <A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000162828025020246/snes-20250424.htm">Schedule 14A</A>, filed with the SEC on April 28, 2025.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
                                            Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025 and June 30, 2025, filed
                                            with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000162828025023925/snes-20250331.htm">May 8, 2025</A> and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1680378/000162828025039024/snes-20250630.htm">August 8, 2025</A>, respectively.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
                                            Current Reports on Form 8-K filed with the SEC on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1680378/000162828025001140/snes-20250108.htm">January 10, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000162828025011846/snes-20250309.htm">March 11, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000162828025030453/snes-20250609.htm">June 10, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390025059251/ea0247463-8k_senes.htm">June 30, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390025059967/ea0247701-8k_senes.htm">July 1, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000162828025034730/snes-20250705.htm">July 10, 2025</A>, and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1680378/000121390025071743/ea0251814-8k_senestech.htm">August 5, 2025</A>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
                                            description of our capital stock contained in our registration statement on <A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000114420416132137/v452318_8a12b.htm">Form 8-A</A> filed
                                            with the SEC on November 7, 2016, including any amendments or reports filed for the purpose
                                            of updating such description (including <A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390020009645/f10k2019a1ex4-1_senestech.htm">Exhibit 4.1</A> to our Amendment No. 1 to the Annual
                                            Report on <A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390020009645/f10k2019a1_senestech.htm">Form 10-K/A</A> for the fiscal year ended December 31, 2019, filed with the SEC on
                                            April 21, 2020).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should rely only on the information incorporated
by reference or provided in this prospectus. We have not authorized anyone else to provide you with any information. You should not assume
that the information incorporated by reference or provided in this prospectus is accurate as of any date other than the date on the front
of each document. You may request a free copy of any or all of the reports or documents incorporated by reference in this prospectus
(other than exhibits, unless they are specifically incorporated by reference in the documents) by writing or telephoning us at the following
address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SenesTech, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">13430 North Dysart Road, Suite 105</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Surprise, Arizona 85379</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Attn: Secretary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(928) 779-4143</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also maintain a website at <I>www.senestech.com</I>
where incorporated reports or other documents filed with the SEC may be accessed. We have not incorporated by reference into this prospectus
the information contained in, or that can be accessed through, our website, and you should not consider it to be part of this prospectus.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 14. Other Expenses of Issuance and Distribution</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the anticipated
costs and expenses payable by us (other than commissions and fees) in connection with the sale of the securities being registered. All
amounts shown are estimates except for the SEC registration fee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: justify">SEC registration fee</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,544.04</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Legal fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,000.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Accounting fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,000.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Printing and miscellaneous fees and expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,455.96</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">110,000.00</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 15. Indemnification of Directors and Officers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Registrant incorporated under the laws of
the State of Delaware. Section 145 of the Delaware General Corporation Law provides that a Delaware corporation may indemnify any persons
who were, are, or are threatened to be made, parties to any threatened, pending or completed action, suit or proceeding, whether civil,
criminal, administrative or investigative (other than an action by or in the right of such corporation), by reason of the fact that such
person is or was an officer, director, employee or agent of such corporation, or is or was serving at the request of such corporation
as an officer, director, employee or agent of another corporation, partnership, joint venture, trust or other enterprise. The indemnification
may include expenses (including attorneys&rsquo; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred
by such person in connection with defending or settling such action, suit or proceeding, provided that such person acted in good faith
and in a manner he or she reasonably believed to be in or not opposed to the corporation&rsquo;s best interests except that no indemnification
is permitted without judicial approval if the officer or director is adjudged to be liable to the corporation. Where an officer or director
is successful on the merits or otherwise in the defense of any action referred to above, the corporation must indemnify him or her against
the expenses (including attorneys&rsquo; fees) actually and reasonably incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Registrant&rsquo;s amended and restated certificate
of incorporation and amended and restated bylaws provide for the indemnification of its directors and officers to the fullest extent
permitted under the Delaware General Corporation Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section&nbsp;102(b)(7) of the Delaware General
Corporation Law permits a corporation to provide in its certificate of incorporation that a director of the corporation shall not be
personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duties as a director, except for
liability for any:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Breach
                                            of director&rsquo;s duty of loyalty to the corporation or its stockholders;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Act
                                            or omission not in good faith or that involves intentional misconduct or a knowing violation
                                            of law;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Unlawful
                                            payment of dividends or unlawful purchase or redemption of shares; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Transaction
                                            from which the director derives an improper personal benefit;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Registrant&rsquo;s amended and restated certificate
of incorporation includes such a provision. Expenses incurred by any officer or director in defending any such action, suit or proceeding
in advance of its final disposition shall be paid by the Registrant upon delivery to it of an undertaking, by or on behalf of such director
or officer, to repay all amounts so advanced if it shall ultimately be determined that such director or officer is not entitled to be
indemnified by the Registrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 174 of the Delaware General Corporation
Law provides, among other things, that a director who willfully or negligently approves of an unlawful payment of dividends or an unlawful
stock purchase or redemption, may be held jointly and severally liable for such actions. A director who was either absent when the unlawful
actions were approved or dissented at the time may avoid liability by causing his or her dissent to such actions to be entered in the
books containing minutes of the meetings of the board of directors at the time such action occurred or immediately after such absent
director receives notice of the unlawful acts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As permitted by the Delaware General Corporation
Law, the Registrant has entered into indemnification agreements with each of its directors and executive officers, that require the Registrant
to indemnify such persons against any and all costs and expenses (including attorneys&rsquo;, witness or other professional fees) actually
and reasonably incurred by such persons in connection with any action, suit or proceeding (including derivative actions), whether actual
or threatened, to which any such person may be made a party by reason of the fact that such person is or was a director or officer or
is or was acting or serving as an officer, director, employee or agent of the Registrant or any of its affiliated enterprises. Under
these agreements, the Registrant is not required to provide indemnification for certain matters, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indemnification
                                            for expenses or losses with respect to proceedings initiated by the director or officer,
                                            including any proceedings against the Registrant or its directors, officers, employees or
                                            other indemnitees and not by way of defense, with certain exceptions;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indemnification
                                            for any proceeding if a final decision by a court of competent jurisdiction determines that
                                            such indemnification is prohibited by applicable law;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indemnification
                                            for the disgorgement of profits arising from the purchase or sale by the director or officer
                                            of securities of the Registrant in violation of Section 16(b) of the Exchange Act, or any
                                            similar successor statute; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indemnification
                                            for the director or officer&rsquo;s reimbursement to the Registrant of any bonus or other
                                            incentive-based or equity-based compensation previously received by the director or officer
                                            or payment of any profits realized by the director or officer from the sale of securities
                                            of the Registrant, as required in each case under the Exchange Act.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The indemnification agreements also set forth
certain procedures that will apply in the event of a claim for indemnification thereunder. Except as otherwise disclosed in our periodic
reports incorporated by reference herein, there is at present no pending litigation or proceeding involving any of the Registrant&rsquo;s
directors or executive officers as to which indemnification is required or permitted, and the Registrant is not aware of any threatened
litigation or proceeding that may result in a claim for indemnification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Registrant has an insurance policy in place,
with limits of $6.0 million in the aggregate, that covers its officers and directors with respect to certain liabilities, including liabilities
arising under the Securities Act or otherwise. Insofar as indemnification for liabilities arising under the Securities Act may be permitted
to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has
been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is,
therefore, unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 16. Exhibits and Financial Statement Schedules</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibits</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit<BR>
    Number</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 90%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000114420416127272/v449283_ex4-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of the Registrant&rsquo;s Common Stock certificate (incorporated by reference to Exhibit&nbsp;4.1 to the Registrant&rsquo;s Amendment No.&nbsp;1 to Registration Statement on Form&nbsp;S-1, filed with the SEC on October&nbsp;7, 2016 (File no.&nbsp;333-213736))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2+</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000114420416140707/v455521_ex4-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Restricted Stock Unit Agreement (incorporated by reference to Exhibit&nbsp;4.1 to the Registrant&rsquo;s Current Report on Form&nbsp;8-K, filed with the SEC on December&nbsp;21, 2016 (File no.&nbsp;001-37941)</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000161577417006784/s108206_ex4-2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant (incorporated by reference to Exhibit&nbsp;4.2 to the Registrant&rsquo;s Amendment No.&nbsp;1 to Registration Statement on Form&nbsp;S-1, filed with the SEC on November 16, 2017 (File no.&nbsp;333-221433))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000161577417006927/s108257_ex4-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Underwriter&rsquo;s Warrant, as amended (incorporated by reference to Exhibit&nbsp;4.1 to the Registrant&rsquo;s Current Report on Form&nbsp;8-K, filed with the SEC on November 21, 2017 (File no.&nbsp;001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000161577418005543/s110939_ex4-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of New Warrant (incorporated by reference to Exhibit&nbsp;4.1 to the Registrant&rsquo;s Current Report on Form&nbsp;8-K, filed with the SEC on June&nbsp;20, 2018 (File no.&nbsp;001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000161577418008053/s111989_ex4-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant issued to investors in Rights Offering (incorporated by reference to Exhibit&nbsp;4.1 to the Registrant&rsquo;s Quarterly Report on Form&nbsp;10-Q, filed with the SEC on August&nbsp;14, 2018 (File no.&nbsp;001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000161577418008053/s111989_ex4-2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant issued to dealer-manager in Rights Offering (incorporated by reference to Exhibit&nbsp;4.2 to the Registrant&rsquo;s Quarterly Report on Form&nbsp;10-Q, filed with the SEC on August&nbsp;14, 2018 (File no.&nbsp;001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000161577418008053/s111989_ex4-3.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Agency Agreement, dated August&nbsp;13, 2018, between the Registrant and Transfer Online, Inc. (incorporated by reference to Exhibit&nbsp;4.3 to the Registrant&rsquo;s Quarterly Report on Form&nbsp;10-Q, filed with the SEC on August&nbsp;14, 2018 (File no.&nbsp;001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390019013000/f8k071119ex4-1_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Placement Agent Warrant (incorporated by reference to Exhibit&nbsp;4.1 to the Registrant&rsquo;s Current Report on Form&nbsp;8-K, filed with the SEC on July&nbsp;17, 2019 (File no.&nbsp;001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390020002007/f8k012320ex4-1_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant (incorporated by reference to Exhibit 4.1 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on January 28, 2020 (File no. 001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390020002007/f8k012320ex4-2_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.2 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on January 28, 2020 (File no. 001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390020005632/ea119372ex4-1_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant (incorporated by reference to Exhibit&nbsp;4.1 to the Registrant&rsquo;s Current Report on Form&nbsp;8-K, filed with the SEC on March 6, 2020 (File no.&nbsp;001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390020005632/ea119372ex4-2_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.2 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on March 6, 2020 (File no. 001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14+</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390020006565/f10k2019ex4-6_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Restricted Stock Unit Agreement (incorporated by reference to Exhibit&nbsp;4.6 to the Registrant&rsquo;s Annual Report on Form&nbsp;10-K, filed with the SEC on March 17, 2020 (File no.&nbsp;001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390020033336/ea128925ex4-1_senestechinc.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of New Warrant (incorporated by reference to Exhibit 4.1 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on October 27, 2020 (File no. 001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390020033336/ea128925ex4-2_senestechinc.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.2 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on October 27, 2020 (File no. 001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390021006124/ea134239ex4-1_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.1 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on February 2, 2021 (File no. 001-37941)</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390021006124/ea134239ex4-2_senestech.htm">Form of Warrant (incorporated by reference to Exhibit 4.2 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on February 2, 2021 (File no. 001-37941)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390021006124/ea134239ex4-3_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.3 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on February 2, 2021 (File no. 001-37941)</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.20</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390021017223/ea138230ex4-1_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.1 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on March 23, 2021 (File no. 001-37941))</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.21</FONT></TD>
    <TD STYLE="text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390022072741/fs12022a1ex4-21_senestech.htm">Form of Series A Warrant (incorporated by reference to Exhibit 4.21 to the Registrant&rsquo;s Registration Statement on Form S-1/A, filed with the SEC on November 15, 2022 (File no. 333-267991))</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.22</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390022072741/fs12022a1ex4-22_senestech.htm">Form of Series B Warrant (incorporated by reference to Exhibit 4.22 to the Registrant&rsquo;s Registration Statement on Form S-1/A, filed with the SEC on November 15, 2022 (File no. 333-267991))</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.23</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390022072741/fs12022a1ex4-23_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.23 to the Registrant&rsquo;s Registration Statement on Form S-1/A, filed with the SEC on November 15, 2022 (File no. 333-267991)) </FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.24</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390022072741/fs12022a1ex4-24_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.24 to the Registrant&rsquo;s Registration Statement on Form S-1/A, filed with the SEC on November 15, 2022 (File no. 333-267991))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.25</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390023010277/ea173036ex4-2_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of SenesTech, Inc. Stock Option Grant Notice and Stand-Alone Option Agreement (incorporated by reference to Exhibit 4.2 to the Registrant&rsquo;s Registration Statement on Form S-8, filed with the SEC on February 10, 2023 (File no. 333-269686))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.26</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390023010277/ea173036ex4-3_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of SenesTech, Inc. Restricted Stock Unit Grant Notice and Stand-Alone Restricted Stock Unit Agreement (incorporated by reference to Exhibit 4.3 to the Registrant&rsquo;s Registration Statement on Form S-8, filed with the SEC on February 10, 2023 (File no. 333-269686))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.27</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390023029094/ea176827ex4-28_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Series C Warrant (incorporated by reference to Exhibit 4.28 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on April 12, 2023 (File no. 001-037941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.28</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390023029094/ea176827ex4-29_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.29 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on April 12, 2023 (File no. 001-037941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.29</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000162828023030170/snes-20230821xexx433.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of New Warrants (incorporated by reference to Exhibit 4.33 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on August 22, 2023 (File no. 001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.30</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390023091021/ea189188ex4-34_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Series D Warrant (incorporated by reference to Exhibit 4.34 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on November 29, 2023 (File no. 001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: -0.125in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.31</FONT></TD>
    <TD STYLE="padding-left: -0.125in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: -0.125in; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390023091021/ea189188ex4-35_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Series E Warrant (incorporated by reference to Exhibit 4.35 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on November 29, 2023 (File no. 001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.32</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390023091021/ea189188ex4-36_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.36 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on November 29, 2023 (File no. 001-37941)) </FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.33</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390023091021/ea189188ex4-37_senestech.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.37 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on November 29, 2023 (File no. 001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.34</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390024072025/ea021223701ex4-1_senes.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Series F-1 Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.1 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on August 23, 2024 (File no. 001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.35</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390024072025/ea021223701ex4-2_senes.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Series F-2 Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.2 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on August 23, 2024 (File no. 001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.36</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390024072025/ea021223701ex4-3_senes.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.3 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on August 23, 2024 (File no. 001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.37</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000162828025011846/snes-20250311xexx41.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Series G Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.1 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on March 11, 2025 (File no. 001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.38</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000162828025011846/snes-20250311xexx42.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Placement Agent Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.2 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on March 11, 2025 (File no. 001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.39</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390025059967/ea024770101ex4-1_senes.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Series H Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.1 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on July 1, 2025 (File no. 001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.40</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390025059967/ea024770101ex4-2_senes.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Placement Agent Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.2 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on July 1, 2025 (File no. 001-37941))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">4.41</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390025071743/ea025181401ex4-1_senestech.htm">Form of Series I Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.1 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on August 5, 2025 (File no. 001-37941))</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">4.42</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1680378/000121390025071743/ea025181401ex4-2_senestech.htm">Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.2 to the Registrant&rsquo;s Current Report on Form 8-K, filed with the SEC on August 5, 2025 (File no. 001-37941))</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1*</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea025346201ex5-1_senestech.htm">Legal Opinion of Greenberg Traurig, LLP</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea025346201ex23-1_senestech.htm">Consent of M&amp;K CPAS, PLLC, independent registered public accounting firm</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2*</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea025346201ex5-1_senestech.htm">Consent of Greenberg Traurig, LLP (contained in Exhibit 5.1)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1*</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#poa_001">Power of Attorney (included on signature page hereof)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107*</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea025346201ex-fee_senestech.htm">Filing Fee Table</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed herewith.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates a management
    contract or compensatory plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(b) Financial Statement Schedules</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No financial statement schedules are provided
because the information called for is not required or is shown either in the financial statements or the notes thereto.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 17. Undertakings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned registrant hereby undertakes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a)(1) To file, during any period in which offers
or sales are being made, a post-effective amendment to this registration statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To include any prospectus
    required by Section&nbsp;10(a)(3) of the Securities Act;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To reflect in the prospectus
    any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof)
    which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement.
    Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
    offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering
    range may be reflected in the form of prospectus filed with the SEC pursuant to Rule&nbsp;424(b) if, in the aggregate, the changes
    in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &ldquo;Calculation
    of Registration Fee&rdquo; table in the effective registration statement;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To include any material
    information with respect to the plan of distribution not previously disclosed in the registration statement or any material change
    to such information in the registration statement;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">provided, however, that paragraphs (a)(1)(i),
(a)(1)(ii) and (a)(1)(iii) do not apply if the information required to be included in a post-effective amendment by those paragraphs
is contained in periodic reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the
Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus
filed pursuant to Rule 424(b) that is part of the registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(2)&nbsp;That, for the purpose of determining
any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating
to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(3)&nbsp;To remove from registration by means
of a post-effective amendment any of the securities being registered that remain unsold at the termination of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(4)&nbsp;That, for the purpose of determining
liability under the Securities Act of 1933 to any purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each prospectus filed by
    the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus
    was deemed part of and included in the registration statement; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each prospectus required
    to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule 430B relating to
    an offering made pursuant to Rule 415(a)(1)(i), (vii) or (x) for the purpose of providing the information required by Section 10(a)
    of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date
    such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering
    described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an
    underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the
    registration statement to which the prospectus relates, and the offering of such securities at that time shall be deemed to be the
    initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part
    of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement
    or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective
    date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration
    statement or made in any such document immediately prior to such effective date.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(5) That, for the purpose of determining liability
of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant
undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless
of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means
of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer
or sell such securities to such purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any preliminary prospectus
    or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any free writing prospectus
    relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The portion of any other
    free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities
    provided by or on behalf of the undersigned registrant; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any other communication
    that is an offer in the offering made by the undersigned registrant to the purchaser.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b) The undersigned registrant hereby undertakes
that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&rsquo;s annual report
pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee
benefit plan&rsquo;s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference
in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(c) Insofar as indemnification for liabilities
arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to
the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against
public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling
person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against
public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form
S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the
City of Surprise, State of Arizona, on the 15<SUP>th</SUP> day of August 2025.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SENESTECH, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 37%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ <FONT STYLE="font-variant: small-caps">Joel
    L. Fruendt</FONT></I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joel L. Fruendt</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>President and Chief Executive Officer</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="poa_001"></A>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">KNOW ALL PERSONS BY THESE PRESENTS, that each
person whose signature appears below constitutes and appoints Joel L. Fruendt and Thomas&nbsp;C. Chesterman, and each of them, as his
or her true and lawful attorneys-in-fact and agents, each with the full power of substitution, for him or her and in his or her name,
place or stead, in any and all capacities, to sign any and all amendments to this registration statement (including post-effective amendments),
and to sign any registration statement for the same offering covered by this registration statement that is to be effective upon filing
pursuant to Rule&nbsp;462(b) promulgated under the Securities Act, and all post-effective amendments thereto, and to file the same, with
exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact
and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done
in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming
all that said attorneys-in-fact and agents, or their, his or her substitute or substitutes, may lawfully do or cause to be done by virtue
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 34%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 45%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 17%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s<FONT STYLE="font-variant: small-caps">/
    Joel L. Fruendt</FONT></I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 15, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joel L. Fruendt</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    <FONT STYLE="font-variant: small-caps">Thomas C. Chesterman</FONT></I></FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Vice President,
    Chief Financial Officer,</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    15, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas C. Chesterman</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasurer and Secretary <BR> (Principal Financial and
    Accounting Officer)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ <FONT STYLE="font-variant: small-caps">Jamie
    Bechtel</FONT></I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chair of the Board</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 15, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jamie Bechtel</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ <FONT STYLE="font-variant: small-caps">Lynn
    Y. Graham</FONT></I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 15, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lynn Y. Graham</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ <FONT STYLE="font-variant: small-caps">Phil
    N. Grandinetti, III</FONT></I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 15, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phil N. Grandinetti, III</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ <FONT STYLE="font-variant: small-caps">Jake
    S. Leach</FONT></I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 15, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jake S. Leach</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 15, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Joshua M. Moss &nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ <FONT STYLE="font-variant: small-caps">Matthew
    K. Szot</FONT></I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 15, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Matthew K. Szot</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">II-7</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea025346201ex5-1_senestech.htm
<DESCRIPTION>LEGAL OPINION OF GREENBERG TRAURIG, LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex5-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">August 15, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SenesTech, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">13430 North Dysart Road, Suite 105</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Surprise, Arizona 85379</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>Re:</B></TD><TD STYLE="text-align: justify"><B>Registration Statement on Form S-3 SenesTech, Inc.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As legal counsel to SenesTech,
Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), we have assisted in the preparation of the Company&rsquo;s Registration
Statement on Form S-3, including the prospectus constituting a part thereof (the &ldquo;<U>Registration Statement</U>&rdquo;), to be filed
with the Securities and Exchange Commission under the Securities Act of 1933, as amended, relating to the registration for resale under
the Registration Statement of an aggregate of 2,261,252 shares (the &ldquo;<U>Registered Shares</U>&rdquo;) of the Company&rsquo;s common
stock, par value $0.001 per share (&ldquo;<U>Common Stock</U>&rdquo;), issuable upon the exercise of warrants originally issued by the
Company in connection with an inducement to exercise certain warrants as follows: (i) 2,188,308 shares of Common Stock issuable upon the
exercise of warrants issued to certain holders in connection with the warrant inducement transaction, and (ii) 72,944 shares of Common
Stock issuable upon the exercise of placement agent warrants issued to designees of the placement agent in connection with the warrant
inducement transaction (together, the &ldquo;<U>Warrants</U>&rdquo;). The facts, as we understand them, are set forth in the Registration
Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With respect to the opinion
set forth below, we have examined originals, certified copies, or copies otherwise identified to our satisfaction as being true copies,
only of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">A.</TD><TD STYLE="text-align: justify">The Amended and Restated Certificate of Incorporation of the Company, as amended;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">B.</TD><TD STYLE="text-align: justify">The Amended and Restated Bylaws of the Company, as amended;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">C.</TD><TD STYLE="text-align: justify">The Warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">D.</TD><TD STYLE="text-align: justify">Resolutions of the Board of Directors of the Company approving, among other things, the issuance of the
Registered Shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">E.</TD><TD STYLE="text-align: justify">The Registration Statement; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">F.</TD><TD STYLE="text-align: justify">Such other documents and records and other certificates and instruments and matters of law as we have
deemed necessary or appropriate to express the opinion set forth below, subject to the assumptions, limitations and qualifications stated
herein.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the assumptions
that (i) the documents and signatures examined by us are genuine and authentic, and (ii) the persons executing the documents examined
by us have the legal capacity to execute such documents, and subject to the further limitations and qualifications set forth below, based
solely upon our review of items A through F above, it is our opinion that the Registered Shares have been duly authorized and, when issued
by the Company upon exercise of the Warrants in accordance with the terms thereof, will be validly issued, fully paid, and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We express no opinion as to
the applicability or effect of any laws, orders, or judgments of any state or other jurisdiction other than federal securities laws and
the substantive laws of the state of Delaware, including judicial interpretations of such laws. Further, our opinion is based solely upon
existing laws, rules, and regulations, and we undertake no obligation to advise you of any changes that may be brought to our attention
after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%">
    <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Greenberg Traurig, LLP | Attorneys at Law</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2375 East Camelback Road | Suite 800 | Phoenix, Arizona 85016 | T +1
    602.445.8000 | F +1 602.445.8100</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-top: Black 1pt solid; text-align: right">www.gtlaw.com&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SenesTech, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">August 15, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We hereby expressly consent
to any reference to our firm in the Registration Statement, inclusion of this Opinion as an exhibit to the Registration Statement, and
to the filing of this Opinion with any other appropriate governmental agency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 60%; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify; width: 40%">Very truly yours,</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;<TD STYLE="text-align: justify"><I>/s/ Greenberg Traurig, LLP</I></TD></TR>
     </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"></P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; font-size: 10pt; font-weight: bold">Greenberg Traurig, LLP | Attorneys at Law</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-top: Black 1pt solid; text-align: right">www.gtlaw.com&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ea025346201ex23-1_senestech.htm
<DESCRIPTION>CONSENT OF M&K CPAS, PLLC, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><IMG SRC="ex23-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">We hereby consent to the inclusion in this
Registration Statement on Form S-3 of our report dated March 13, 2025, of SenesTech, Inc. relating to the audit of the financial statements
as of and for the periods ending December 31, 2024 and 2023 and the reference to our firm under the caption &ldquo;Experts&rdquo; in the
Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 40%">/s/ M&amp;K CPAS, PLLC</TD>
    <TD STYLE="width: 60%">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">www.mkacpas.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The Woodlands, Texas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">August 15, 2025</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ea025346201ex-fee_senestech.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FE.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.2b -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: 646d45f908e986cbac6d2bc4dff5e834 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">S-3</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0001680378</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001680378</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-14</xbrli:startDate>
          <xbrli:endDate>2025-08-14</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001680378</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-14</xbrli:startDate>
          <xbrli:endDate>2025-08-14</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_004">S-3</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_005">SenesTech, Inc.</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="fee_006">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="fee_007">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="fee_008">Common Stock, par value $0.001 per share</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="fee_009">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_010">2,261,252</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_011">4.46</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_012">10,085,183.92</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_013">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_014">1,544.04</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_015">10,085,183.92</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_016">1,544.04</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_017">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_018">1,544.04</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="fee_019">Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement shall also cover any additional shares of SenesTech, Inc. (the &#8220;Registrant&#8221;) common stock, par value $0.001 per share (&#8220;Common Stock&#8221;), that may become issuable by reason of any stock dividend, stock split, recapitalization, or any other similar transaction that results in an increase in the number of outstanding shares of Common Stock of the Registrant.<br/><br/>The amount registered represents (i) 2,188,308 shares of Common Stock issuable upon the exercise of warrants issued to certain holders in connection with the warrant inducement and (ii) 72,944 shares of common stock issuable upon the exercise of warrants issued to designees of the placement agent in connection with the warrant inducement.<br/><br/>Pursuant to Rule 457(c) under the Securities Act, the proposed maximum offering price per share and the proposed maximum aggregate offering price for the shares have been calculated solely for the purpose of computing the registration fee on the basis of the average high and low prices of the Registrant&#8217;s Common Stock as reported by the Nasdaq Stock Market LLC on August 12, 2025.<br/></ix:nonNumeric></td></tr>
  </table>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  U 7,# 2(  A$! Q$!_\0
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MIS>,KWE!/1JWYGG8+),5B\)A\3_:M=>WI1J62J.W,MKPK4UT_E3Z-L_RK_\
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M><V^IO;1&WN)(I)G<?TE?\-9_LJ]_P!I?]GXGN1\9_AQU[_\S+ZU_G:>-O\
M@@#_ ,%6U\;>,Q#^S3'XEBD\6>(YX?$-C\3?AU<V>O0W6K7EU%K%K=7_ (AM
M+V:'4HI4NE>^MK:\!F\FZ@CG1U'-?\. O^"K^3_QB=+_ .'&^&!''ICQ3C\N
M#7G1Q-6C*<:>72C'FWAIS--ZOW>STZ(^9I8_%8-UHX7(:T(3JRDY4[J-1WMS
M:0=^KOHM=+[G^C<W[6?[*O0?M,?L^C/K\:/AP,_^7+_G-?Q>?\'3OQ6^&'Q1
M^,W[(,OPT^(W@/XBP:+\,?BG%K$_@3Q?X?\ %L.DSW_BCPL;"'4Y]!U&_AL9
M+Y;6Y-K'<.LLPMYI(XFBBE9?S2;_ ((!?\%7^,_LFS'KC'Q%^&''_ET_E7Q7
M^U/^PY^T]^Q!KGA'PU^TU\+KCX7:OX^TC4]>\)6TFN>'=>CUK3M$N[:PU66*
MX\.:IJ4,4UC=7MI');7#1S[+F*54,;[JPQ>*KU*%2,L+5I1E:\M9<MFM;66^
MVZL<>:YKF&(P->A4RNO0IU$DZTG)\MFG;E]FEK;^9>1\M?Y[?TX_+BBBBO$/
MB3^J#]GG_@Y"_;T^(O[77P@\!^,-&^"$?PL^(WQT\+>"=8\)V/@JZL=2TKPQ
MXQ\70:$+*P\5?VT]^-3TFVU&!K;5+J*=;J[M?]*MI1</&/[Q8U8%E4AE1L$%
M0A...P  X/*  D'\/\K7_@IM^R3\1/V OVZOBAX(EL=3\.Z)-X^O_BS^SYXQ
MMHVM;?5O ^J>(I?$GA'4O#^H >0VJ^#-0,>@ZG;0O-/8:MHZ2S(@N8BW]3W[
M#O\ P<\_LY^+/A_X;\)_MM:;XF^$'Q;TC3[#2==^(GAOPU>>+?ACXUNK6$6\
MGB9[70_M.O\ @G4=36-;S4]%N].U'2K2]FF73=3FA(M8/H<)BG"I5H8JHHU4
MU:4M(V3\DEZ=[Z'Z%DV:3HU<7@\VKM8FG6:A*J^5*,4[Q4TH_+HUI=[']3>M
MZ!I'B/3-1T3Q!I&FZ[H>K6<UAJVBZU8VNJ:3JEC/&8IK+4=.O8I[*^LYD9UF
MM;NWGAD#L"G//^>[_P '$O\ P3=^#?[$GQ?^$?Q=_9\TNT\$_#3]HV3QO::A
M\+K!B= \%^//!@T6^U>Y\(6TI_XE'ACQ!8Z_;3G08'^R:3JUM=KIJ6UA<0VM
MM_4GXI_X.#?^"47AK0;O6;?]J&V\6W%M;&X70/"'PZ^(^I^(+D@ _9K:RN_#
M.F6SW!SM6.2^B 8$M(%Z?Q=_\%D/^"J%S_P4R^,GA#4O"_A;5/ 7P(^#>GZQ
MI/PT\/\ B&:"3Q/K.H^(I[6;Q%XY\3PV4T]E8W^K1Z;IMCIVAZ?<W+Z=IMJH
MO+JXO)YMM8ZMAIT'!U*<ZDI1Y.362:[M:I=]?O*XBQF6XC+ZE.-2E5Q$G%T/
M9OFG&491N[J\DM5HG9]M#^G+_@U>^./B?XA?L3?%;X0^(;RYU"Q^ 7QGDTWP
MA-=RO,=-\+>/_#]IXIC\.VC.6VZ?I>MQZY=VB!F$7]JR0HWDQ0JG*_\ !PA_
MP5$_;#_8.^+'[/'P\_9A\:^&/ ^E>//A]XO\9>+-0U7P/H7B[5-1U"P\166B
MZ9:6\NO0W,&FV-G!Y\[+:0B6[N)P;AVC@A0?6?\ P;I_L=>,/V5/V"H/$?Q*
MT2\\-_$+]HWQ=+\7;SP]J5J]CJVA^"IM'L-(^'EAJ]E*B3VNI7>B6TWB*6VF
M5)K6#7[:SFAAGMY4K\0_^#M#_DY?]DH<9_X4?XWX./\ H>[7&<D#''<@=>13
MK.I1RZ+4Y1J1C%<R;3LV[:Z/X;+6[L:8NIB<+PW3G[2=/$0HTO?4FI*[;5]O
MLN.CV6A_0I_P0O\ VR/C?^W/^Q(OQ@_:&U70O$'Q'T;XL>// $VOZ!H%EX6@
MU?1="72+S2KB]T;3-NF0ZC!%JCV<T]G! MQ%;0R21"<SO+^S)3TQTQ@_S)&.
M:_AV_P""''_!8K]B#]A']C35/@K^T+XH\?Z#X^N/C+XY\:QV?ASX;^(/%>F2
M:#XAL]!CTR8:GI"RP+=;K&ZCN;21898#$C 2+('/['G_ (.6_P#@E7U/Q#^+
MF3_U1+QMU_\  ;\<#Z#&*VP^*@Z%'VE>DINE%M<VMWN]7UTZ[W.[+LRPTL!@
MWB,71=9482GS5%=SV;:;T?JNM[=3]^#%DCIU!/'.1T(/T&.<@=@*D)P.WXGC
M\\?TK\ O^(EK_@E4>/\ A8GQ;4GC)^"?C7CMD_Z-V/)]N*^O/V+_ /@KU^Q!
M^WG\1M;^$G[/7Q!\4:I\0]"\+W/C.;P]XO\  ?B+P9<W_A^PO[/3M4OM+DU:
MV%M?#3;O4M-6]MDECG@COK9PDBF0ITQK4IM15:$Y=(Q:?X79WPQV"G)0IXJA
M*<F^6"J)N3ZV2=_DCXB_X.><G_@EWJIXX^/WP9Z'/_+[KG^/J:_#_P#X-.O^
M3U_VF!_>_99M#]-OQ7\'+T[YZ_I[U^W_ /P<[DG_ ()=:MGG_B_OP9(X.<?;
M=<<Y&!C"\GT4;CQDU^'_ /P:>9'[:_[2_7C]EBSQ]/\ A;'@TMCUZ@GTR.F1
M7!5?_"C1_P #2]+2_P SY_%Z\2X/:[CA[6V_@XS;KV/[LO&_@_PS\0/"/BCP
M'XUT6Q\2>$/&6@:KX8\3>'M2A2?3];T+7+&?3=4TZZ@<%7BO+*XFB8<$;MR,
MK!6'^6Y_P46_8S^(O_!,3]M?7/AUH.K:WINBZ/KFG_%K]FSXD6S7%GJ%UX-3
M5SJ7A+4;34%VHWB7P%JUJ-"UGRY#(FI:4MVRBWU&%7_U3<(^ 0>!QR01VX(/
M'O@\C@U^+?\ P7"_X)S6_P"WW^R;JDG@C1X)_P!H;X%QZM\0/@U/'#&+SQ%M
ML'/BWX;/-C<]OXSTNW5-+A=MEOXHL=%N5'E&Z27HQF']M34HJU6DU.$M;I1N
MY1TWOINGJO,]#/,OEC,.JU+W,5A$ZM*25VG%-R6N[:U5T]59;G\#W_!0[]L6
MX_;O^._A_P#:&UK39-'\9:K\$_A/X.^(MFL21Z=+\0_ ^@?V/XGU?0C&J@Z#
MKEW =7TV%\2V7V^:R90L*N_^@_\ \$)^?^"2G[$A]?ACK'_JP_&A_K7^7W-!
M-!+/;75O<6MS;S36UW:W<;PW=K=V\IAN+:[AD^>*[MIXFAN(W DBFC9& 8$5
M_J!_\$)S_P :E/V)!G_FF.M_D/B+XS _2O,RV4JF(Q,YN[E2]YZ7?[Q+HET2
M_,^<X5J5JV88NIB+NJZ%Y3>\VJR3DUHD[KLNI^6W_!PA_P %4/VQ_P!A+XV_
ML_\ PN_9A\9>%? NB^-?A9XA\?\ BO4M4\#Z%XOU?5=3@\6R^';"QCE\0175
MOI^G65O:-<[+*"&XNKBZE%S.\<<"Q_H__P $,_VR/C?^W1^PW9_&?]H34]!U
MSXE:/\6_B'\.;K7O#^@6?AF#6]'\-1^'[W2;R^TC3@-.M]1CCUR2TN)+&*WB
MN4M+:XDB^T/.[_SE_P#!V8?^,N?V6/\ LW#Q"1SCI\3M2R?PXR>W%=__ ,$.
MO^"QO[$?["'[%M]\#OVAO%?CW0?'LGQN^(/CJ&T\/?#3Q)XMTR?PYXGT_P +
MPZ3-'JVDH]LMV7TB[6YM)-MQ R)(\8CFC)Z8U^7,,1"I5Y:2I0M&4K1YK1=_
M)Z;+_(]2EF$J7$..I8C$N&'C2M"$YJ,%)1IM--[.[;LGJ?W";&]/U%)Y;<MP
M,@9 QU&<ELC!!!QCT ]Z_ P?\'+G_!*T_P#-0_BT/K\$?&X_]MZ8W_!RY_P2
MN#$#XB?%O..@^"/C4CD9[P=@.G')]3BNZ->E?2O2>FSG?]7^GJ>Y/-,NBKRQ
MF'2OI>JM^F[/WW8$QE!@?+C(.< =@ <]!C@Y';%?R"_\%I?^"VG[9?[#_P"V
MO??L[? &S^%&E^#=!^%W@3Q5<ZMXM\&R^*-?UG6O&@U6YN7>>XU6VMK2PL(;
M.ULK&UL[8-,ZSR74LSNHB_<#]C+_ (*Z_L3?M[_$'7_A;^SO\0?$.J^//#WA
MJ7Q=<^'/%O@/Q#X+O-0\/VUW;V-]>Z+)J\*6^I_8+F]LXKZWAD%Q$EPLZHT
M=D_G)_X.F_V+_&-O\0/A;^W5X4T6\U?P3J'@_3?@S\7;^SMY;M?!^MZ-JFI7
M?P^U[5C&I%EHFO6^N:CX?2];9'#K5K8P7-S;OJ%DDF&,J57AYRP\DY0<9*=/
M6UI>\M;WTLW9:+[SASC$U7ED\5EU52G"4)<]*T[P3]Y:J2O9J_5)]$?U*?\
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M#/VY=',\:ZI)XS^"6J"R9U$QT\>&_'5HUVL>2S0K=;8&? VR2(K 9!/[3?\
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MZ5*$KUJCM?EY?6R6BTO?4^;/@3_P<C_M]?$+]J[X:>!-0\/_  ,U[X9_$O\
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M\R/S%:9EI@ZEF]8ZZ_WTO78[.(92658RS>D</9]?>K6EKOJM'O9=C^1O_/\
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%=KU/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  F .T# 2(  A$! Q$!_\0
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M3FU;W).]K?#NU>V^^CW^\\$_X-1/^4HFL_\ 9KGQ9_\ 4J^&5?Z3%?P'?\$
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MOQT_9MFUCXP0Z;C$(U_4?#>NVF@:]J-HK>5'?W-N)KF.*)[QIIVFEDE^"?\
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MK.6[NKUYYYI:_$#]MW4_^"=>L_LN_'?XR?L#_P#!/;]JFWU_P5>:MX^^&_\
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MW-P^H%87@D'EMYD?ER *6JUT4;?/EDOOU2/QO_X*2>,/V>OAU_P5;\$^(?\
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@#J=^(--T#3-,LO,NYI)(7;R_+**!W=K7T_KRO^)__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex23-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !; = # 2(  A$! Q$!_\0
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MPA>Z;%']HETC1?BEI^I>)A"HW,L=A:S7$EQ<;>!;VEK<SLP*I"[80R?LZ_\
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M\<:G8R2VYGL]/TEM2TOPU=7,+*T=EKURES/<P%E%]%H[6DF^"6:&7^<4:Z%
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M/#'A[PQ98 ^R>'M%TW1;7"_='V?3;:VBPO8;,#M70T5%.TJ03/#$)YDBD:*
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MX-_#_39'!NX/"5CXN^(FN0QY7<(XKZR\#Z09<%@C?VE-&K*-RNIK]I_V0_\
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MVV]Q$A^8D[BI;MG  KR5=#LU4*MSK:JH"JJ^)?$:JJ@8"JJZJ J@      8
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1+O\ ,UC+F5VK>5[_ (V1_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Aug. 14, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001680378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">SenesTech, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Aug. 14, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">2,261,252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">4.46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 10,085,183.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 1,544.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement shall also cover any additional shares of SenesTech, Inc. (the &#8220;Registrant&#8221;) common stock, par value $0.001 per share (&#8220;Common Stock&#8221;), that may become issuable by reason of any stock dividend, stock split, recapitalization, or any other similar transaction that results in an increase in the number of outstanding shares of Common Stock of the Registrant.<br/><br/>The amount registered represents (i) 2,188,308 shares of Common Stock issuable upon the exercise of warrants issued to certain holders in connection with the warrant inducement and (ii) 72,944 shares of common stock issuable upon the exercise of warrants issued to designees of the placement agent in connection with the warrant inducement.<br/><br/>Pursuant to Rule 457(c) under the Securities Act, the proposed maximum offering price per share and the proposed maximum aggregate offering price for the shares have been calculated solely for the purpose of computing the registration fee on the basis of the average high and low prices of the Registrant&#8217;s Common Stock as reported by the Nasdaq Stock Market LLC on August 12, 2025.<br/><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Aug. 14, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 10,085,183.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">1,544.04<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 1,544.04<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>19</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea025346201ex-fee_senestech.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea025346201ex-fee_senestech.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea025346201ex-fee_senestech.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ea025346201ex-fee_senestech.htm">ea025346201ex-fee_senestech.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="17">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea025346201ex-fee_senestech.htm": {
   "dts": {
    "inline": {
     "local": [
      "ea025346201ex-fee_senestech.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 19,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 1,
    "http://xbrl.sec.gov/ffd/2025": 2
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 17,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025346201ex-fee_senestech.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025346201ex-fee_senestech.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025346201ex-fee_senestech.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025346201ex-fee_senestech.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025346201ex-fee_senestech.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025346201ex-fee_senestech.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001213900-25-077488-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-077488-xbrl.zip
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M<\C!^==/73BM\0F<@J!VV[78Z!,;;Z9;U!HZ2%BIZL7]ZBJ:^3F](A."]9B
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M,#(U,S0V,C Q97@M9F5E7W-E;F5S=&5C:"YH=&U02P4&      $  0!-
&:@L

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>ea025346201ex-fee_senestech_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680378</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-14</startDate>
            <endDate>2025-08-14</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680378</identifier>
        </entity>
        <period>
            <startDate>2025-08-14</startDate>
            <endDate>2025-08-14</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">S-3</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0001680378</dei:EntityCentralIndexKey>
    <ffd:FormTp contextRef="c_report" id="fee_004">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_005">SenesTech, Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="fee_006">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="fee_007">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="fee_008">Common Stock, par value $0.001 per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_1" id="fee_009">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="fee_010"
      unitRef="shares">2261252</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_011"
      unitRef="USD">4.46</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_012"
      unitRef="USD">10085183.92</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_013"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_014"
      unitRef="USD">1544.04</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_015"
      unitRef="USD">10085183.92</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_016"
      unitRef="USD">1544.04</ffd:TtlFeeAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_017"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_018"
      unitRef="USD">1544.04</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="fee_019">Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this Registration Statement shall also cover any additional shares of SenesTech, Inc. (the &#x201c;Registrant&#x201d;) common stock, par value $0.001 per share (&#x201c;Common Stock&#x201d;), that may become issuable by reason of any stock dividend, stock split, recapitalization, or any other similar transaction that results in an increase in the number of outstanding shares of Common Stock of the Registrant.&lt;br/&gt;&lt;br/&gt;The amount registered represents (i) 2,188,308 shares of Common Stock issuable upon the exercise of warrants issued to certain holders in connection with the warrant inducement and (ii) 72,944 shares of common stock issuable upon the exercise of warrants issued to designees of the placement agent in connection with the warrant inducement.&lt;br/&gt;&lt;br/&gt;Pursuant to Rule 457(c) under the Securities Act, the proposed maximum offering price per share and the proposed maximum aggregate offering price for the shares have been calculated solely for the purpose of computing the registration fee on the basis of the average high and low prices of the Registrant&#x2019;s Common Stock as reported by the Nasdaq Stock Market LLC on August 12, 2025.&lt;br/&gt;</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
